Exodus Point Capital Management, LP Precigen, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.41 - $2.79 $27,530 - $54,474	-19,525 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$1.15 - $2.53 $969 - $2,132	-843 Reduced 4.14%	19,525 $26,000
Q1 2022 May 13, 2022	SELL	$1.91 - $3.98 $178,369 - $371,680	-93,387 Reduced 82.09%	20,368 $43,000
Q4 2021 Feb 11, 2022	BUY	$3.53 - $5.5 $146,660 - $228,508	41,547 Added 57.54%	113,755 $422,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $77,260 - $101,413	15,483 Added 27.29%	72,208 $360,000

Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $173,166 - $228,113	27,751 Added 95.78%	56,725 $370,000
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $75,831 - $123,198	11,251 Added 63.48%	28,974 $200,000
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $95,437 - $268,752	-25,450 Reduced 58.95%	17,723 $181,000
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $107,005 - $189,552	30,573 Added 242.64%	43,173 $151,000
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $27,216 - $68,796	12,600 New	12,600 $63,000

142

145M

208K

43.7K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $329M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.